Feeds:
Posts
Comments

Search Results for 'Nebivolol'


Bidness ETC FDA Advisory votes against approving Actavis nebivolol/valsartan combo The Pharma Letter Nebivolol (marketed in the USA as Bystolic by Actavis subsidiary Forest Labs) is indicated for the treatment of hypertension and is effective at… Source: http://www.thepharmaletter.com See on Scoop.it – Cardiotoxicity

Read Full Post »


Bystolic’s generic Nebivolol – Positive Effect on circulating Endothelial  Progenitor Cells Endogenous Augmentation Curator: Aviva Lev-Ari, PhD, RN   Bystolic’s generic Nebivolol – FDA approved for Treatment of Hypertension since 2008 – Pharmacological agent hypothesized to have positive effect on circulating Endothelial  Progenitor Cells (cEPCs) endogenous augmentation: Low number of cEPCs found to be associated with […]

Read Full Post »


Top Articles by Number of e-Readers for All Days ending 2019-02-17 (Summarized)   All Time Title Views Home page / Archives 603,640 Is the Warburg Effect the Cause or the Effect of Cancer: A 21st Century View? 16,748 Do Novel Anticoagulants Affect the PT/INR? The Cases of XARELTO (rivaroxaban) and PRADAXA (dabigatran) 13,287 Paclitaxel vs […]

Read Full Post »


Dynamic Contents for LPBI Group’s PowerPoint Presentation   The source material used in the creation of LPBI Group’s PowerPoint Presentation is from Nomination for 2018 Yidan Prize, recognition in the field of MEDICAL education: development of curation methodologies for scientific content – 2018 Nominee, Aviva Lev-Ari, PhD, RN https://pharmaceuticalintelligence.com/2018/10/21/nomination-for-2018-yidan-prize-recognition-in-the-field-of-medical-education-development-of-curation-methodologies-for-scientific-content-2018-nominee-aviva-lev-ari-phd-rn/ WORK-in-PROGRESS   Challenges and Opportunities for […]

Read Full Post »


Article Title, Author/Curator’s Name and Article Views >1,000, 4/2012 – 1/2019 @pharmaceuticalintelligence.com   Reporter: Aviva Lev-Ari, PhD, RN   Expert, Author, Writer’s Initials Name & Bio Roles @LPBI Group LHB Larry Bernstein, MD, FACP,   Member of the Board Expert, Author, Writer – All Specialties of Medicine & Pathology Content Consultant to Series B,C,D,E Editor, Series […]

Read Full Post »


Nomination for 2018 Yidan Prize, recognition in the field of MEDICAL education: development of curation methodologies for scientific content – 2018 Nominee, Aviva Lev-Ari, PhD, RN   March 31, 2018 Yidan Prize for Education Development recognizes innovative ideas that tackle pressing challenges in the field of education. Nomination for recognition as means in tackling challenges […]

Read Full Post »


Data Science is the Greatest Science! It is the Greatest Science for Women, as well Curator: Aviva Lev-Ari, PhD, RN   UPDATED ON 3/2/2018 The Growing Influence of Analytics on the C-Suite     This curation has three parts: Part 1: Account of a Data Scientist, Aviva Lev-Ari, PhD – worked in Data Science, 1976-2005 […]

Read Full Post »


Reflections on a Four-phase Career: Aviva Lev-Ari, PhD, RN, March 2018   Prepared for publication in American Friends of the Hebrew University (AFHU), May 2018 Newsletter, Hebrew University’s HUJI Alumni Spotlight Section. The profile was up on 5/3/2018 on AFHU website under the Alumni Spotlight at https://www.afhu.org/ Excerpts were Published in AFHU e-news on 5/11/2018. https://us10.campaign-archive.com/?u=5c25136c60d4dfc4d3bb36eee&id=757c5c3aae&e=d09d2b8d72 https://www.afhu.org/2018/05/03/aviva-lev-ari/ Aviva Lev-Ari, PhD, RN – February […]

Read Full Post »


CHI’s Discovery on Target, Sheraton Boston, Sept. 25-28, 2018 Reporter: Aviva Lev-Ari, PhD, RN   ANNOUNCEMENT Leaders in Pharmaceutical Business Intelligence (LPBI) Group is a selected CHI Business Partner for Media Communication for this event as well a provider of REAL TIME PRESS COVERAGE for this cardinal event in the domain of  Drug Discovery and Drug Delivery. Dr. Aviva […]

Read Full Post »


Updated on 4/14/2019 –>> FIVE years of e-Scientific Publishing @pharmaceuticalintellicence.com, Top Articles by Author and by e-Views >1,000, 4/27/2012 to 1/29/2018 UPDATED on 4/14/2019 Top Posts for all days ending 2019-04-14 (Summarized) All Time Title Views Home page / Archives 615,383 Is the Warburg Effect the Cause or the Effect of Cancer: A 21st Century […]

Read Full Post »

Next »